January 8, 2002, read first time and referred to Committee on Public Health.
Introduced
Second Regular Session 112th General Assembly (2002)
PRINTING CODE. Amendments: Whenever an existing statute (or a section of the Indiana
Constitution) is being amended, the text of the existing provision will appear in this style type,
additions will appear in
this style type, and deletions will appear in
this style type.
Additions: Whenever a new statutory provision is being enacted (or a new constitutional
provision adopted), the text of the new provision will appear in
this style type. Also, the
word
NEW will appear in that style type in the introductory clause of each SECTION that adds
a new provision to the Indiana Code or the Indiana Constitution.
Conflict reconciliation: Text in a statute in
this style type or
this style type reconciles conflicts
between statutes enacted by the 2001 General Assembly.
HOUSE BILL No. 1058
A BILL FOR AN ACT concerning health.
Be it enacted by the General Assembly of the State of Indiana:
SOURCE: ; (02)IN1058.1.1. -->
SECTION 1. P.L.291-2001, SECTION 81, IS AMENDED TO
READ AS FOLLOWS [EFFECTIVE DECEMBER 30, 2001
(RETROACTIVE)]: SECTION 81. (a) The Indiana prescription drug
advisory committee is established to:
(1) study pharmacy benefit programs and proposals, including
programs and proposals in other states; and
(2) make initial and ongoing recommendations to the governor for
programs that address the pharmaceutical costs of low-income
senior citizens.
(b) The committee consists of eleven (11) members appointed by
the governor and four (4) legislative members. The term of each
member expires December 31,
2001. 2004. The members of the
committee appointed by the governor are as follows:
(1) A physician with a specialty in geriatrics.
(2) A pharmacist.
(3) A person with expertise in health plan administration.
(4) A representative of an area agency on aging.
(5) A consumer representative from a senior citizen advocacy
organization.
(6) A person with expertise in and knowledge of the federal
Medicare program.
(7) A health care economist.
(8) A person representing a pharmaceutical research and
manufacturing association.
(9) Three (3) other members as appointed by the governor.
The four (4) legislative members shall serve as nonvoting members.
The speaker of the house of representatives and the president pro
tempore of the senate shall each appoint two (2) legislative members,
who may not be from the same political party, to serve on the
committee.
(c) The governor shall designate a member to serve as chairperson.
A vacancy with respect to a member shall be filled in the same manner
as the original appointment. Each member is entitled to reimbursement
for traveling expenses and other expenses actually incurred in
connection with the member's duties. The expenses of the committee
shall be paid from the Indiana prescription drug account created by
IC 4-12-8
, as added by this act. The office of the secretary of family
and social services shall provide staff for the committee. The
committee is a public agency for purposes of
IC 5-14-1.5
and
IC 5-14-3.
The
advisory council committee is a governing body for
purposes of
IC 5-14-1.5.
(d) Not later than September 1,
2000, 2004, the
board committee
shall make program design recommendations to the governor and the
family and social services administration concerning the following:
(1) Eligibility criteria, including the desirability of incorporating
an income factor based on the federal poverty level.
(2) Benefit structure.
(3) Cost-sharing requirements, including whether the program
should include a requirement for copayments or premium
payments.
(4) Marketing and outreach strategies.
(5) Administrative structure and delivery systems.
(6) Evaluation.
(e) The recommendations shall address the following:
(1) Cost-effectiveness of program design.
(2) Coordination with existing pharmaceutical assistance
programs.
(3) Strategies to minimize crowd-out of private insurance.
(4) Reasonable balance between maximum eligibility levels and
maximum benefit levels.
(5) Feasibility of a health care subsidy program where the amount
of the subsidy is based on income.
(6) Advisability of entering into contracts with health insurance
companies to administer the program.
(f) The committee may not recommend the use of funds from the
Indiana prescription drug account for a state prescription drug benefit
for low-income senior citizens if there is a federal statute or program
providing a similar prescription drug benefit for the benefit of
low-income senior citizens.
(g) This SECTION expires December 31, 2001. 2004.